ABSTRACT
During early pregnancy, uterine mucosa decidualization is accompanied by a drastical enrichment of CD56 high CD16
negative NK cells. Decidual NK (dNK) cells differ from peripheral blood NK (pbNK) cells in several ways, but their origin is still unclear.
Our results demonstrate that chemokines present in the uterus can support pbNK cell migration through human endothelial and stromal decidual cells. Notably, we observed that pregnant women pbNK cells are endowed with higher migratory ability with respect to nonpregnant women or male donor pbNK cells. Moreover, NK cell migration through decidual stromal cells was increased when progesterone-cultured stromal cells were used as substrate, and this correlated with the ability of progesterone to up-regulate stromal cell chemokine expression. Furthermore, we demonstrate that also dNK cells can migrate through stromal cells using a distinct pattern of chemokines. Finally, we found that pbNK cells acquire a chemokine receptor pattern very similar to that of dNK cells when contact decidual stromal cells.
Collectively these results strongly suggest that pbNK cell recruitment to the uterus contributes to the accumulation of NK cells during early pregnancy; that progesterone plays a crucial role in this event; and that pbNK cells undergo reprogramming their chemokine receptor profile once exposed to uterine microenvironment. During development and activation, NK cells acquire a multiple cell surface receptor system including both activating and inhibitory receptors that finely control their functional activation (4) . Some of these receptors are oligoclonally distributed and/or are expressed at different density on circulating NK cells. Based on cell surface density of these receptors, phenotypically distinct pbNK cell populations have been identified, and suggested to represent specialized subsets capable of performing different functions and endowed with distinct migratory properties (5) .
Mature NK cells mainly circulate in the peripheral blood, but are also present in several lymphoid and non-lymphoid organs such as spleen, lymph nodes, tonsils, liver, lungs, intestine and uterus (1, (6) (7) (8) . Interestingly, NK cells are the most abundant class of lymphocytes found in the mucosal tissues of maternal uterus where their number reaches 70-80% of the total leukocytes in the first trimester of pregnancy, then start to decline and return to basal levels at the end of pregnancy (7) (8) (9) negative NK cell subset, display a unique transcriptional profile (10) .
Although dNK cells express a number of activating receptors (such as: NKp30, NKp44, NKp46, CD244) and are endowed with an intact cytolytic machinery, they are poorly cytotoxic and fail to polarize the microtubule-organizing center and the cytolytic granules toward the synapse (11, 12) .
Numerical variations of uNK cells have been also described during the mestrual cycle with their number increasing in the proliferative phase and reaching the maximal level in the late secretory phase. These uNK cell numerical variations have been correlated to hormoneinduced decidualization rather than to the embryo implantation and to changes in chemokine expression in decidual tissues (13) (14) (15) . Inside the uterine compartment, NK cells are found as single cells or aggregates around endometrial glands and vessels where they might play a crucial role for normal development of placenta and/or its vasculature and uterine tissue remodeling, by producing cytokines, chemokines and angiogenic factors (14, 16, 17) .
The origin of dNK cells is presently unknown and it is still debated whether they arise from NK cell progenitors present in the uterus prior pregnancy or recruited from other tissues, and/or from NK cell populations recruited from blood (18, 19) .
Studies aimed at understanding the molecules potentially involved in the control of NK cell accumulation in the uterus, have shown that first trimester human NK cells express a distinct pattern of adhesion molecules and chemokine receptors as compared to both CD56 high and CD56 low peripheral blood counterparts. In particular, dNK cells exhibit high levels of αEβ7, α1β1, αXβ2, αDβ2, whereas do not express the laminin receptor α6β1. They also display the β5 integrin subunit and selectively express high levels of tetraspan 5, CD151 and CD9 tetraspanins (10, 17, (20) (21) (22) . In regard to the chemokine receptor profile, dNK cells differently from the pbNK cell counterpart exhibit higher levels of CXCR3, lower levels of CXCR4, and very low or undetectable levels of CXCR1 or CXCR2, CX3CR1 or only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From 5 CCR1, 2,3,5,6,7 (23-25) . Moreover, evidences indicating the ability of trophoblast or endometrial cells to produce chemokines acting on pbNK cells and dNK cells, have been provided (23, 24, 26, 27) .
Although all these findings indicate that dNK cells express several adhesion molecules and chemotactic receptors that might control their migration and localization into different uterine compartments, data showing the ability of NK cells to migrate through decidual tissues are still lacking, nor it is known whether the mild systemic inflammatory status already observed in early pregnancy results in an enhanced migratory ability of pbNK cells into the uterine compartment.
Here we analyzed whether pbNK cell recruitment to the uterus may contribute to the accumulation of NK cell number in this non-lymphoid organ during early pregnancy, by evaluating the ability of pbNK cells from both pregnant women and non-pregnant women or male donors, to migrate throughout endothelial and stromal decidual cells, and the effect of progesterone in these events. We also studied the ability of stromal cells to support dNK cell migration that can be relevant for their specific localization inside the uterine compartment.
Finally, we studied whether the chemokine receptor profile of pbNK cells may undergo tissue specific modulation when these cells contact stromal or endothelial cells in the uterus.
MATERIALS AND METHODS

Cells
Human pbNK and dNK cell purification: mononuclear cells were isolated from peripheral blood of Decidual human endothelial (DEC) and stromal (ST) cell purification: endothelial and stromal cells from decidual tissues of women undergoing elective pregnancy termination were purified as previously described with some modifications (28, 29) . Briefly, decidual tissues were digested overnight at 4°C with 0.25% trypsin (Sigma-Aldrich), 50µg/ml DNase1 (Boehringer Mannheim, Germany) in PBS and then treated with collagenase type I (3mg/ml) (Worthington Biochemical Figure S1 ). DEC were cultured using Endothelial Serum Free Basal Medium (GIBCO) supplemented with 20 ng/ml bFGF, 10 ng/ml EGF and penicillin (50 U/ml)/streptomycin (50 µg/ml). 
RNase Protection Assay and real time quantitative PCR analysis
RNase Protection Assay: RNase protection assay was performed using RiboQuant multiprobe kit (BD Biosciences Pharmingen, San Diego, CA) according to the manufacture's instructions. Briefly, 32 P radiolabeled probe set hCK5 was hybridized with 8µg of RNA from DEC and ST decidual cells.
Samples were then digested with RNase and the remaining "RNase-protected" probes were purified, resolved on a sequencing gel and identified by size. Undigested probes were used as reference size marker and L32 and GAPDH transcripts as RNA loading control. As negative control 
Immunofluorescence and flow cytometric analysis
Chemokine receptor expression on freshly isolated pbNK cells or dNK cells was evaluated by performing a three color immunofluorescence staining. Cells were washed with PBS and incubated with chemokine receptor specific mAb against human CCR1, CCR5, CXCR1 (R&D System, Minneapolis, MN), CXCR4 (BD Biosciences) or purified rabbit anti-human CX3CR1 (Torrey Pines Biolabs, Inc, Houston, TX) or with integrin specific mouse mAb against human CD18, CD11a, CD11b, CD11c, CD29, CD49d, CD49e, or rat mAb against CD49f (Immunotech S.A, Marseille, France) for 30 min on ice, followed by anti-mouse, or anti-rabbit, or anti-rat Ig fluorochrome conjugated secondary F(ab')2 Ab (GAM, GARB and GART respectively), (Cappel Laboratories, Cooper Biomedical Inc., Malvern, PA); cells were then incubated for 15 min with normal mouse serum, and then anti-CD3 and anti-CD56 fluorochrome-conjugated mAbs were simultaneous added only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From for additional 30 min at 4°C. Staining of CXCR3 was performed using PE-conjugated anti-CXCR3 mAb (R&D) and using PE-conjugated mouse IgG (BD Biosciences) as control Ab. For fluorescence measurement only data from 10000 to 30000 single cell events were collected using a standard FACScalibur flow cytometer and data were analyzed using CELLQuest (BD Biosciences). 
Migration assay
Cell migration was measured using a Transwell migration chamber (diameter insert 6.5 mm, pore Fig.1 panels A, B, C and D) , while only ST cells express detectable levels of CCL5/Rantes and CCL4/MIP-1β ( Fig.1 panel A) . By performing real time quantitative PCR analysis on primary cultures of DEC and ST cells derived from the same donor, we found that CXCL10/IP-10 mRNA was expressed at similar levels on both DEC and ST cells, while CX3CL1/Fractalkine and CCL2/MCP-1 were mainly expressed by DEC, and CXCL12/SDF-1 by ST cells (Fig.1 panel D) . For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From CXCL10 /IP-10 as chemoattractants. As control, we used highly purified NK cells isolated from normal male donors as well as from women in the first week of cycle exhibiting low sex hormone levels.
As shown in Fig.3 , we found that pbNK cells from first trimester pregnant women have an higher ability to migrate through DEC (Fig.3, panels A) and ST cells (Fig.4, panels A) with respect to the NK cells derived from male donors (Fig.3 and Fig.4, panel B) or from nonpregnant women (Fig.3 and Fig.4, panel C) (Fig.4 , panels B and C) without affecting that of NK cells isolated from first trimester pregnant women (Fig.4, panel A) . By contrast, progesterone treatment of DEC did not change the migratory behaviour of all the pbNK cell populations assayed (see Figure S6 ). These data show for the first time, that pbNK cells are able to migrate through both DEC and ST tissues, and this capacity is strongly enhanced during early pregnancy; they also suggest that fluctations of progesterone levels occurring during early pregnancy tightly control this process by acting on ST cells.
dNK cell migration through decidual ST cells.
To investigate the ability of ST cells to support also dNK cell migration, freshly isolated highly purified dNK and pbNK cells derived from the same donor, were allowed to migrate These data indicate that dNK and pbNK cells use a distinct pattern of chemokines to migrate through ST cells; this result strongly correlates with the levels of CXCR4, CX3CR1 and CXCR3 expression found on dNK versus pbNK cells (see Figure S5) . Among factors involved in the control of the good outcome of pregnancy, crucial actors are sex hormones and evidences indicate that numerical variations of NK cells in the decidua or in the late secretory phase of mestrual cycle parallel progesterone levels (13, 14) . However, as NK cells do not express the progesterone receptors, the effect of this hormone in the control of NK cell accumulation in the uterus has been mainly attributed to its ability to induce endometrial decidualization.
Endometrial decidualization is a process associated with many functional and phenotypic modifications and an enhanced expression of CXCL9/MIg, CXCL10/IP-10 and CX3CL1/Fractalkine have been described (25, 41, 42) . Moreover, a cyclical variability in the expression levels of chemokines found in the endometrium during endometrial breakdown, repair or embryo implantation as well as changes in the functional adhesiveness of pbNK cells to decidual vascular endothelial cells associated to early pregnancy have been described (15, 30, 31) .
Notably, we observed that pbNK cells from first trimester pregnant women display higher migratory capacity as compared to pbNK cells of non-pregnant women or male donors even if they express comparable levels of chemokine receptors or integrin subunits (see Table S1 ), thus suggesting that pregnancy associated factors acting at systemical level including hormones such as prolactin, chorionic gonadotrophin, oestrogens and/or inflammatory cytokines such as IL-12 and IL-18, can modulate the migratory behaviour of pbNK cells without affecting their integrin and chemokine receptor profile.
The finding that migration of NK cells from pregnant women differently from that of nonpregnant women or male donors, is not enhanced when progesterone-treated ST cells were used, may be attributable to their higher migratory ability that probably does not allow to designed the research; A.S., and A.G. designed the research and wrote the paper.
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